Mn complex-mediated enhancement of antitumor response through modulating myeloid-derived suppressor cells in
Satyajit Das1, Kaushik Banerjee1, Susmita Roy2
1Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata, India.
Background:
The tumor microenvironment (TME) renders tumor cells more resistant to chemotherapy. However, effective immunomodulators for cancer therapy are still elusive. We hypothesized that Mn-N-(2-hydroxyacetophenone) glycinate (MnNG), reported to be an antitumor agent, can modulate the TME.
Materials And Methods:
Immunomodulatory effects of MnNG were performed through assessing Myeloid Derived Suppressor Cells (MDSCs), Interferon-γ (Ifnγ)- and Interleukin-4 (Il4)-secreting Cluster of Differentiation 4 (Cd4)(+) T-cells by annexin V-binding assay in drug-resistant TME and T-cell proliferation following in vitro co-culture assay by flow cytometry.
Results:
MnNG induced infiltration of Ifnγ-secreting Cd4(+) T-cells and reduces MDSC numbers in vivo. Furthermore, it modulated differentiation of MDSCs towards dendritic cells with up-regulation of co-stimulatory molecules and reversed the suppressive function of MDSC's that enhances T-helper cell 1 (Th1) response. MnNG treatment resulted in reduced expression of IL4, but enhanced expression of Ifnγ when Cd4(+) T-cells were co-cultured with MDSCs.
Conclusion:
MnNG modulates MDSCs differentiaton towards dendritic cells and enhances Th1 response in drug-resistant TME, leading to immunomodulatory efficacy.
Insights
Mn-N-(2-hydroxyacetophenone) glycinate (MnNG) enhances anti-tumor immunity by modulating the tumor microenvironment. It reduces suppressive myeloid-derived suppressor cells and promotes T-helper 1 cell responses, improving cancer therapy efficacy.
Area of Science:
- Immunology
- Cancer Biology
- Pharmacology
Background:
- The tumor microenvironment (TME) often confers resistance to chemotherapy.
- Developing effective immunomodulators for cancer therapy remains a challenge.
Purpose of the Study:
- To investigate the immunomodulatory effects of Mn-N-(2-hydroxyacetophenone) glycinate (MnNG) on the tumor microenvironment.
- To assess MnNG's potential as an anti-cancer therapeutic agent.
Main Methods:
- Assessed myeloid-derived suppressor cells (MDSCs) and Cluster of Differentiation 4 (Cd4)(+) T-cells (secreting Interferon-γ [Ifnγ] and Interleukin-4 [Il4]) using annexin V-binding assay.
- Evaluated T-cell proliferation via in vitro co-culture assay and flow cytometry in a drug-resistant TME.
- Analyzed MDSC differentiation, co-stimulatory molecule expression, and T-helper cell 1 (Th1) response.
Main Results:
- MnNG treatment increased Ifnγ-secreting Cd4(+) T-cell infiltration and decreased MDSC numbers in vivo.
- MnNG modulated MDSC differentiation into dendritic cells, up-regulating co-stimulatory molecules and reversing MDSC suppressive functions.
- Co-culture of Cd4(+) T-cells with MDSCs showed reduced Il4 and enhanced Ifnγ expression after MnNG treatment.
Conclusions:
- MnNG effectively modulates MDSC differentiation towards dendritic cells within the drug-resistant TME.
- MnNG enhances the T-helper cell 1 (Th1) immune response, demonstrating significant immunomodulatory efficacy.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Differentiation of Common Myeloid Progenitor Cells


